SkyePharma progresses on injectables sale
This article was originally published in Clinica
Executive Summary
London, UK-based drug delivery specialist SkyePharma said on December 27 that its exclusive negotiations with a potential buyer for its injectables business are expected to be "concluded shortly". Any disposal will be subject to shareholder approval, it said.